Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Payables (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Payables for 14 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • Quarterly Payables rose 13.36% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2025, up 13.36% year-over-year, with the annual reading at $2.8 million for FY2025, 13.36% up from the prior year.
  • Payables hit $2.8 million in Q4 2025 for STRATA Skin Sciences, down from $3.0 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $10.4 million in Q1 2021 to a low of $1.7 million in Q3 2024.
  • Historically, Payables has averaged $3.9 million across 5 years, with a median of $3.1 million in 2023.
  • Biggest five-year swings in Payables: crashed 76.96% in 2021 and later soared 76.17% in 2022.
  • Year by year, Payables stood at $2.8 million in 2021, then rose by 21.37% to $3.4 million in 2022, then dropped by 2.39% to $3.3 million in 2023, then fell by 27.22% to $2.4 million in 2024, then rose by 13.36% to $2.8 million in 2025.
  • Business Quant data shows Payables for SSKN at $2.8 million in Q4 2025, $3.0 million in Q3 2025, and $2.9 million in Q2 2025.